Arcus Biosciences, Inc. (RCUS) Debt by Year
Arcus Biosciences, Inc. carried $99.0M in long-term debt against $222.0M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 106.3% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Arcus Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RCUS Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RCUS Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $101.0M+4.1% | $100.0M+108.3% | $99.0M+106.3% | $98.0M+108.5% | $97.0M | $48.0M | $48.0M | $47.0M | N/A | N/A | $0 | N/A |
| Cash & Equivalents | $150.0M-39.5% | $201.0M+4.7% | $222.0M+48.0% | $238.0M+18.4% | $248.0M+59.0% | $192.0M+3.8% | $150.0M+18.1% | $201.0M+9.2% | $156.0M-32.2% | $185.0M-22.3% | $127.0M-38.3% | $184.0M-15.6% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Arcus Biosciences, Inc. financials
Frequently Asked Questions
What was Arcus Biosciences, Inc.'s long-term debt in fiscal year 2025?
Arcus Biosciences, Inc. carried $99.0M in long-term debt against $222.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Arcus Biosciences, Inc.'s long-term debt growing?
Arcus Biosciences, Inc. (RCUS) long-term debt rose by 106.3% year over year, from $48.0M to $99.0M in fiscal year 2025.
What was Arcus Biosciences, Inc.'s long-term debt in the most recent quarter?
Arcus Biosciences, Inc. (RCUS) reported $101.0M in long-term debt in Q2 2026. This represents an increase of 4.1% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Arcus Biosciences, Inc. (RCUS) reported on that line in every period on record.